false

  • Our research false false
  • Ageing and neurodegeneration false false
  • Computational Neuroimaging true true

/content/dam/corporate/images/brain-mind-centre/july/compneuro.jpg

50%

Computational Neuroimaging

Using Artificial Intelligence to improve diagnostic brain imaging

m-hero--simple

1280.1280.jpeg 1280w, 1440.480.2x.jpeg 2880w, 800.267.2x.jpeg 1600w, 440.147.2x.jpeg 880w, 220.73.2x.jpeg 440w

false

Focused on transforming neuroradiology services and translational neuroimaging research through innovations in artificial Intelligence (AI), imaging engineering, advanced imaging biomarkers and informatics and improving quality of care for degenerative neurological diseases.

_self

Research, industry or professional?

h2

Partner with us

cmp-call-to-action--ochre

_self

FLERA

h2

Accelerating translational research through Federated Learning

cmp-call-to-action--grey

Who we are

Our team comprises of experts in clinical neuroscience, neuroimaging, and computer science, using Artificial Intelligence algorithms and advanced imaging analytics to provide insights into the cause and progression of neurological diseases.

Through the development of more accurate and descriptive neurological imaging, new biomarkers will be used in research, clinical trials and clinical practice, to aid the diagnosis and monitoring of brain diseases.

Team leadership: Prof Michael BarnettProf Fernando CalamanteProf Dacheng Tao, Professor Emeritus John PollardA/Prof Weidong (Tom) Cai, and Dr Chenyu (Tim) Wang.

Our research areas

Recent progress in magnetic resonance imaging (MRI) technology and artificial intelligence (AI) has opened new doors for both fundamental and clinical investigations in the field of clinical neuroscience.

Our team has achieved considerable success in the area of imaging biomarker research, specifically by employing advanced imaging analytics and developing state-of-the-art deep learning algorithms, with a particular focus on patients with neurodegenerative disease such as multiple sclerosis (MS).

The scope of our imaging biomarker research has expanded to encompass a variety of neurological disorders, such as Motor Neurone Disease, Epilepsy, Essential Tremor, Parkinson's disease, dementia, and Ataxia, among others. Our work spans disease diagnostics, monitoring of disease progression, and investigation into disease mechanisms. Our team extends a multitude of engaging opportunities for collaborative imaging research, industry partnerships, and bespoke research endeavours.

Our approach

Seamless integration of imaging and world-class clinical care with research, education, and industry (including Pharma) is the backbone of our group. The multidisciplinary synthesis of clinical medicine, research and industry while centred with clinical care, ensures accelerated “bench-to-bedside translation” of our research activity.

Current research programs

Our team

Dr Marinda Taha

Dr Ryan Sullivan 

Dr Linda Ly

Jessie Fu

Joy Wang

Dr Luping Zhou

Dr Mariano Cabezas

Dr Dongnan Liu

Dr Arkiev D'Souza

Dr Linda Ly

Dr Justin Garber

Dr Heidi Beadnall

Dr Sicong Tu

Dr Jinglei Lv

Dr Tonima Ali

Dr Jiajun Deng

Dr Dongang Wang

Dr Geng Zhan

Dr Zihao Tang

Yang Ma

Yixiong Shi

Kain Kyle

Shwe Phyo Han

Jieting Long

Peilin Liu 

Sheng Chen

Our partners

Contact us

Connect

Brain and Mind Centre

Phone: +61 2 9351 0774
Emailbrainandmind.info@sydney.edu.au

94 Mallett Street, Camperdown NSW 2050

Opening hours: Monday to Friday, 9am to 5pm